The identification of a CD47-blocking “hotspot” and design of a CD47/PD-L1 dual-specific antibody with limited hemagglutination

Ítems similars

• Identification of a hotspot on PD-L1 for pH-dependent binding by monoclonal antibodies for tumor therapy
  per: Liu, Hongchuan, et al.
  Publicat: (2020)
• The FG Loop of PD-1 Serves as a “Hotspot” for Therapeutic Monoclonal Antibodies in Tumor Immune Checkpoint Therapy
  per: Chen, Danqing, et al.
  Publicat: (2019)
• CD47-Blocking Antibodies and Atherosclerosis
  per: John J. Ryan, MD
  Publicat: (2016-08-01)
• CD47-Blocking Antibodies and Atherosclerosis
  per: Ryan, John J.
  Publicat: (2016)
• Dual blockage of both PD-L1 and CD47 enhances immunotherapy against circulating tumor cells
  per: Lian, Shu, et al.
  Publicat: (2019)